Investor Relations

Presentations

Receive E-mail AlertsE-mail Alerts
DateTitle
05/04/17
Download Documentation Deutsche Bank 42nd Annual Health Care Conference Presentation
05/04/17
Download Documentation Vanda Pharmaceuticals Inc. at Deutsche Bank 42nd Annual Health Care Conference
05/02/17
Download Documentation Q1 2017 Vanda Pharmaceuticals Inc. Earnings Conference Call
03/21/17
Download Documentation Oppenheimer 27th Annual Healthcare Conference Presentation
03/21/17
Download Documentation Vanda Pharmaceuticals Inc. at the Oppenheimer 27th Annual Healthcare Conference
02/15/17
Download Documentation Vanda Pharmaceuticals Q4 2016 Earnings Call Transcript
02/15/17
Download Documentation Q4 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call
11/02/16
Download Documentation Vanda Pharmaceuticals Q3 2016 Earnings Call Transcript
07/27/16
Download Documentation Vanda Pharmaceuticals Q2 2016 Earnings Call Transcript
06/09/16
Download Documentation Jefferies Healthcare Conference Presentation
05/04/16
Download Documentation Vanda Pharmaceuticals Q1 2016 Earnings Call Transcript
02/10/16
Download Documentation Vanda Pharmaceuticals Q4 2015 Earnings Call Transcript
11/03/15
Download Documentation Vanda Pharmaceuticals Q3 2015 Earnings Call Transcript
07/29/15
Download Documentation Vanda Pharmaceuticals Q2 2015 Earnings Call Transcript
05/06/15
Download Documentation Vanda Pharmaceuticals Q1 2015 Earnings Call Transcript
06/24/13
Download Documentation ENDO 2013 - SET study / tasimelteon for Non-24-Hour Disorder
06/24/13
Download Documentation ENDO 2013 - RESET study / tasimelteon for Non-24-Hour Disorder
01/23/13
Download Documentation Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder - Conference Call Transcript
12/18/12
Download Documentation Vanda Pharmaceuticals Inc. Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder- Conference Call Transcript
06/11/12
Download Documentation Seventy Percent of Totally Blind People with Sleep Complaints Are Not Entrained to the 24 Hour Clock
06/11/12
Download Documentation Pleiomorphic Expression of N24HSWD in the Totally Blind
06/11/12
Download Documentation Significant Sleep Impairment in Totally Blind Individuals with N24HSWD
06/11/12
Download Documentation Timing and Duration of Nap Episodes are Coincident with Melatonin Acrophase
06/11/12
Download Documentation A National Registry of Totally Blind Individuals with Sleep-Wake Complaints
Get help downloading or viewing the above file types
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy